High Purity Ghk-Cu Copper Peptide Cosmetic Raw Material Skin Support Beauty Ingredient

Name: High Purity Ghk-Cu Copper Peptide Cosmetic Raw Material Skin Support Beauty Ingredient
Brand: Beijing Lingyan Biotechnology Co., Ltd.
SKU: 1988233221

Beijing, ChinaBeijing Lingyan Biotechnology Co., Ltd.

US$8.00-20.00

1 Box

Sample price:US$60.00/piece.Request sample

Product profile

Customization

Available

Classification

High Purity Material

Grade

Model NO.

peptide powder

Specific Usage

Normal Use

Content

Standard

Usage

Normal Use

Source

Extract Natural Things

Habit Appellation

Peptide

Application

Normal Use

Property

Protein and Peptide

Suitable for

Peptides

Purity

>99%

Gender

Unisex

Volatile

Not Volatile

Grade Standard

Janoshik

Side Effect

Efficacy

Peptides

Colour

White

Actual Peptide Content

Exceed The Standard

Storage

Store in a Closed Container in a Cool, Dry Place

Transport Package

Concealed Transportation

Specification

5mg 10mg 20mg 50m 100mg etc

Trademark

lingyan

Origin

China

HS Code

2933360000

Production Capacity

100000vials/Month

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceFast DeliveryLow MOQ

Beijing Lingyan Biotechnology Co., Ltd.

Beijing, China

CertifiedBusiness Type: Trading Company CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc.Export Year: 2025-06-03Nearest Port: HongKongAverage Response Time: ≤6.30hTerms of Payment: T/T, LC

AI-Powered supplier vetting

SummaryThe supplier presents itself as a China-based OEM/ODM biotechnology and life-science manufacturing provider, covering recombinant protein expression, fermentation and scale-up, protein purification, and custom peptide synthesis from research through commercial supply. It reports quality assurance, raw-material traceability, documented corrective/preventive-action and complaint-handling procedures, and service quotations under FOB, EXW, CFR, and CIF terms. However, no certification evidence, customer cases, overseas agents or branches, overseas warehouses/showrooms, or in-stock capacity is provided. Financial records show zero values for the stated revenue and profitability indicators for the reported periods, which limits financial credibility assessment and may indicate unavailable or inactive reported operations. Its stated production and customization scope is broad, but some supporting operational evidence remains incomplete.

Supplier typeThe supplier is described as a China-based biotechnology, pharmaceutical, and life-science OEM/ODM manufacturer and technical-service provider. Its stated business scope also includes food additives, feed raw materials, cosmetics, and Class I and II medical devices, indicating a manufacturing and commercial supplier profile rather than a pure trading profile.

After-Sales capabilityThe supplier has a documented corrective and preventive action mechanism and a customer-complaint process, both reported as having followed records. However, it has no overseas agents or branches, no overseas warehouse or showroom, no in-stock capacity, and no stated overseas service countries, so its international after-sales coverage appears limited.

Production capacityThe supplier states that it supports laboratory, pilot, and large-scale manufacturing, including batch and fed-batch fermentation, scale-up, protein purification, peptide synthesis, and OEM supply. It reports average lead times within 15 workdays in both peak and off-season and identifies five qualified service-capability suppliers, supporting a stated production-service capability, although detailed facility capacity and validation records are not provided.

Customization capabilityCustomization is explicitly supported through OEM/ODM production, custom technical services, custom peptide synthesis, process design, gene cloning and vector construction, expression-system selection, process optimization, and flexible support from early development to commercial supply. This is direct evidence of broad customization across development and manufacturing stages.